`
`Subject:
`
`Sent:
`
`Sent As:
`
`Attachments:
`
`KCI LICENSING, INC. (ipdocket@dykema.com)
`
`U.S. TRADEMARK APPLICATION NO. 86856090 - ION PROGRESS - 709800.3676
`
`4/19/2016 11:01:16 AM
`
`ECOM108@USPTO.GOV
`
`Attachment - 1
`Attachment - 2
`Attachment - 3
`
`UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
`
`OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
`
`U.S. APPLICATION SERIAL NO. (cid:160) 86856090
`
`(cid:160) M
`
`ARK: ION PROGRESS
`
`CORRESPONDENT ADDRESS:
`(cid:160)(cid:160)
`(cid:160)(cid:160) (cid:160) (cid:160) PAMELA B. HUFF
`
`(cid:160)(cid:160)
`
`(cid:160) (cid:160) (cid:160) (cid:160) DYKEMA GOSSETT PLLC
`
`(cid:160) (cid:160) (cid:160)(cid:160)(cid:160)(cid:160) 112 EAST PECAN STREET, SUITE 1800
`
`(cid:160) (cid:160) (cid:160)(cid:160) (cid:160) (cid:160) SAN ANTONIO, TX 78205
`
`(cid:160) (cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160) (cid:160) (cid:160)
`
`(cid:160)(cid:160)(cid:160)(cid:160)
`
`APPLICANT: KCI LICENSING, INC.
`
`(cid:160) (cid:160)(cid:160)
`
`*86856090*
`
`CLICK HERE TO RESPOND TO THIS
`LETTER:
`
`http://www.uspto.gov/trademarks/teas/response_forms.jsp
`
`VIEW YOUR APPLICATION FILE
`
`CORRESPONDENT’S REFERENCE/DOCKET
`
`NO:(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`CORRESPONDENT E-MAIL ADDRESS:(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`(cid:160)(cid:160)(cid:160)
`
`(cid:160) 709800.3676
`
`ipdocket@dykema.com
`
`OFFICE ACTION
`
`STRICT DEADLINE TO RESPOND TO THIS LETTER
`TO AVOID ABANDONMENT OF APPLICANT’S TRADEMARK APPLICATION, THE USPTO MUST RECEIVE APPLICANT’S
`COMPLETE RESPONSE TO THIS LETTER WITHIN 6 MONTHS OF THE ISSUE/MAILING DATE BELOW.
`
`(cid:160) I
`
`SSUE/MAILING DATE: 4/19/2016
`
`TEAS PLUS OR TEAS REDUCED FEE (TEAS RF) APPLICANTS – TO MAINTAIN LOWER FEE, ADDITIONAL
`REQUIREMENTS MUST BE MET, INCLUDING SUBMITTING DOCUMENTS ONLINE:(cid:160) Applicants who filed their application
`online using the lower-fee TEAS Plus or TEAS RF application form must (1) file certain documents online using TEAS, including responses to
`Office actions (see TMEP §§819.02(b), 820.02(b) for a complete list of these documents); (2) maintain a valid e-mail correspondence address;
`and (3) agree to receive correspondence from the USPTO by e-mail throughout the prosecution of the application.(cid:160) See 37 C.F.R. §§2.22(b),
`2.23(b); TMEP §§819, 820.(cid:160) TEAS Plus or TEAS RF applicants who do not meet these requirements must submit an additional processing fee of
`$50 per international class of goods and/or services.(cid:160) 37 C.F.R. §§2.6(a)(1)(v), 2.22(c), 2.23(c); TMEP §§819.04, 820.04.(cid:160) However, in certain
`situations, TEAS Plus or TEAS RF applicants may respond to an Office action by authorizing an examiner’s amendment by telephone without
`
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`
`
`incurring this additional fee.(cid:160)(cid:160)
`
`The referenced application has been reviewed by the assigned trademark examining attorney.(cid:160) Applicant must respond timely and completely to
`the issue(s) below.(cid:160) 15 U.S.C. §1062(b); 37 C.F.R. §§2.62(a), 2.65(a); TMEP §§711, 718.03.
`
`DATABASE SEARCH
`
`The trademark examining attorney has searched the Office’s database of registered and pending marks and has found no conflicting marks that
`would bar registration under Trademark Act Section 2(d).(cid:160) TMEP §704.02; see 15 U.S.C. §1052(d).
`
`DISCLAIMER
`
`Applicant must disclaim the wording “ION” because it merely describes an ingredient, quality, characteristic, function, feature, purpose, or use
`of applicant’s goods and/or services, and thus is an unregistrable component of the mark. (cid:160) See 15 U.S.C. §§1052(e)(1), 1056(a); DuoProSS
`Meditech Corp. v. Inviro Med. Devices, Ltd., 695 F.3d 1247, 1251, 103 USPQ2d 1753, 1755 (Fed. Cir. 2012) (quoting In re Oppedahl & Larson
`
`LLP, 373 F.3d 1171, 1173, 71 USPQ2d 1370, 1371 (Fed. Cir. 2004)); TMEP §§1213, 1213.03(a).(cid:160)(cid:160)
`
`The attached evidence from third party websites:
`
`(cid:160) h
`
`(cid:160) h
`
`(cid:160) h
`
`ttp://enzysurge.com/enzysurge.com/originals/1426852199SAWC%20Spring%202012%20SilverStream_Powers.pdf
`
`ttp://alliqua.com/wp-content/uploads/2013/10/SilverIon_SAWC2013_Pstr-Final.pdf
`
`ttp://www.infectioncontroltoday.com/articles/2008/03/cabg-wound-care-best-practices-are-elusive.aspx
`
`(cid:160) d
`
`emonstrates this wording is commonly used in connection with similar goods and/or services to identify silver ions being used in the treatment
`of wounds.(cid:160) Therefore, the wording “ION” merely describes the goods and services.
`
`An applicant may not claim exclusive rights to terms that others may need to use to describe their goods and/or services in the marketplace.(cid:160) See
`Dena Corp. v. Belvedere Int’l, Inc. , 950 F.2d 1555, 1560, 21 USPQ2d 1047, 1051 (Fed. Cir. 1991); In re Aug. Storck KG, 218 USPQ 823, 825
`(TTAB 1983).(cid:160) A disclaimer of unregistrable matter does not affect the appearance of the mark; that is, a disclaimer does not physically remove
`the disclaimed matter from the mark.(cid:160) See Schwarzkopf v. John H. Breck, Inc., 340 F.2d 978, 978, 144 USPQ 433, 433 (C.C.P.A. 1965); TMEP
`
`§1213.(cid:160)(cid:160)
`
`If applicant does not provide the required disclaimer, the USPTO may refuse to register the entire mark.(cid:160) See In re Stereotaxis Inc., 429 F.3d
`1039, 1040-41, 77 USPQ2d 1087, 1088-89 (Fed. Cir. 2005); TMEP §1213.01(b).
`
`(cid:160) A
`
`pplicant should submit a disclaimer in the following standardized format:
`
`No claim is made to the exclusive right to use “ION” apart from the mark as shown.
`
`(cid:160) F
`
`or an overview of disclaimers and instructions on how to satisfy this disclaimer requirement online using the Trademark Electronic Application
`System (TEAS) form, please go to
`
`CLASSIFICATION AND IDENTIFICATION OF SERVICES
`
`(cid:160)
`(cid:160)
`(cid:160)(cid:160)
`(cid:160)
`(cid:160)(cid:160)
`(cid:160)
`(cid:160)
`
`
`The identification listed in int. class 10 “Surgical and medical apparatus and equipment; therapeutic and healthcare products; medical devices
`wound therapy devices including homecare sub-atmospheric wound therapy device; parts and accessories for all of the foregoing goods” is
`unacceptable as indefinite because it could identify goods that are properly classified in more than one class.(cid:160) For example “surgical glues”;
`“medical adhesives for binding wounds” are properly classified in int. class 5.
`
`(cid:160) A
`
`pplicant must amend the identification to specify the common commercial name of the goods.(cid:160) If there is no common commercial name,
`applicant must describe the product and its intended uses.(cid:160) See id.
`
`(cid:160) T
`
`he identification for the class 42 services appears to be acceptable as written.
`
`(cid:160) A
`
`s to the class 44 recitation of services, the wording “providing information related to advanced wound care, negative pressure wound therapy,
`and therapeutic support systems” and “monitoring report medical conditions of individuals” in the “medical diagnostic monitoring and
`reporting services, namely, monitoring report medical conditions of individuals” must be clarified.
`
`(cid:160) I
`
`nformation services are classified according to the subject matter of the information provided.(cid:160) TMEP §1402.11(b).(cid:160) Therefore, to enable proper
`classification and examination of the application, applicant must specify the subject matter of the “information”. (cid:160) Furthermore it is not clear what
`“monitoring report medical conditions of individuals” is meant to identify.
`
`(cid:160) T
`
`he applicant may adopt the following, if accurate:
`
`(cid:160) I
`
`nt. class 10; Surgical and medical apparatus and equipment, namely ___[specify by common commercial name]; therapeutic and healthcare
`products, namely ___[specify by common commercial name]; medical devices, namely ___[specify by common commercial name]; wound
`therapy devices namely homecare sub-atmospheric wound therapy device; replacement parts for all of the foregoing goods;
`
`(cid:160) I
`
`nt. class 42; Software as a service (SAAS), namely, services featuring software for providing medical, health, and wellness information
`accessible through remote connectivity module equipped devices
`
`(cid:160) I
`
`nt. class 44; Medical services; providing medical information related to advanced wound care, negative pressure wound therapy, and therapeutic
`support systems; monitoring, tracking, and reporting medical conditions, medical data, and medical records, namely, remote monitoring of data
`indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; medical diagnostic
`monitoring and reporting services, namely, monitoring the report of medical conditions of individuals.
`
`An applicant may only amend an identification to clarify or limit the goods and/or services, but not to add to or broaden the scope of the goods
`and/or services.(cid:160) 37 C.F.R. §2.71(a); see TMEP §§1402.06 et seq., 1402.07.
`
`For assistance with identifying and classifying goods and services in trademark applications, please see the USPTO’s online searchable U.S.
`Acceptable Identification of Goods and Services Manual at http://tess2.uspto.gov/netahtml/tidm.html. (cid:160) See TMEP §1402.04.
`
`(cid:160) T
`
`he application identifies goods and/or services in more than one international class; therefore, applicant must satisfy all the requirements below
`for each international class based on Trademark Act Section 1(b):
`
`(1)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`(2)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`List the goods and/or services by their international class number in consecutive numerical order, starting with the lowest
`numbered class.
`
`Submit a filing fee for each international class not covered by the fee(s) already paid (view the USPTO’s current fee schedule at
`http://www.uspto.gov/trademarks/tm_fee_info.jsp).(cid:160) The application identifies goods and/or services that are classified in at least 4
`
`(cid:160)
`(cid:160)(cid:160)(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`
`
`classes; however, applicant submitted a fee(s) sufficient for only 3 class(es).(cid:160) Applicant must either submit the filing fees for the
`classes not covered by the submitted fees or restrict the application to the number of classes covered by the fees already paid.
`
`(cid:160) S
`
`ee 15 U.S.C. §§1051(b), 1112, 1126(e); 37 C.F.R. §§2.32(a)(6)-(7), 2.34(a)(2)-(3), 2.86(a); TMEP §§1403.01, 1403.02(c).
`
`(cid:160) F
`
`or an overview of the requirements for a Section 1(b) multiple-class application and how to satisfy the requirements online using the Trademark
`Electronic Application System (TEAS) form, please go to http://www.uspto.gov/trademarks/law/multiclass.jsp.
`
`INFORMATION ABOUT GOODS AND SERVICES
`
`To permit proper examination of the application, applicant must submit additional information about the goods and services.(cid:160) See 37 C.F.R.
`§2.61(b); In re AOP LLC, 107 USPQ2d 1644, 1650-51 (TTAB 2013); In re Cheezwhse.com, Inc., 85 USPQ2d 1917, 1919 (TTAB 2008); In re
`Planalytics, Inc., 70 USPQ2d 1453, 1457-58 (TTAB 2004); TMEP §814.(cid:160) The requested information should include fact sheets, instruction
`manuals, brochures, and/or advertisements.(cid:160) If these materials are unavailable, applicant should submit similar documentation for goods and
`services of the same type, explaining how its own product or services will differ.(cid:160) If the goods and services feature new technology and no
`information regarding competing goods and services is available, applicant must provide a detailed factual description of the goods and services.
`
`(cid:160) F
`
`actual information about the goods must make clear how they operate, salient features, and prospective customers and channels of trade.(cid:160) For
`the services, the factual information must make clear what the services are and how they are rendered, salient features, and prospective
`customers and channels of trade.(cid:160) Conclusory statements will not satisfy this requirement for information.
`
`(cid:160) T
`
`he applicant must also address the following question:(cid:160) do the goods and services use/discuss/provide information of silver ion being used in the
`treatment of wounds?
`
`(cid:160) F
`
`ailure to comply with a request for information can be grounds for refusing registration.(cid:160) In re AOP LLC, 107 USPQ2d at 1651; In re DTI
`P’ship LLP , 67 USPQ2d at 1701-02; TMEP §814.(cid:160) Merely stating that information about the goods and services is available on applicant’s
`website is an inappropriate response to a request for additional information and is insufficient to make the relevant information of record.(cid:160) See In
`re Planalytics, Inc., 70 USPQ2d at 1457-58.
`
`(cid:160)(cid:160)(cid:160)
`
`ASSISTANCE
`
`If applicant has questions regarding this Office action, please telephone or e-mail the assigned trademark examining attorney.(cid:160) All relevant e-
`mail communications will be placed in the official application record; however, an e-mail communication will not be accepted as a response to
`this Office action and will not extend the deadline for filing a proper response.(cid:160) See 37 C.F.R. §§2.62(c), 2.191; TMEP §§304.01-.02, 709.04-.05.(cid:160)
`Further, although the trademark examining attorney may provide additional explanation pertaining to the refusal(s) and/or requirement(s) in this
`Office action, the trademark examining attorney may not provide legal advice or statements about applicant’s rights. (cid:160) See TMEP §§705.02,
`709.06.
`
`(cid:160)(cid:160)(cid:160)(cid:160)
`
`/Karen K. Bush/
`
`(cid:160) T
`
`O RESPOND TO THIS LETTER: (cid:160) Go to http://www.uspto.gov/trademarks/teas/response_forms.jsp. (cid:160) Please wait 48-72 hours from the
`issue/mailing date before using the Trademark Electronic Application System (TEAS), to allow for necessary system updates of the application.(cid:160)
`For technical assistance with online forms, e-mail TEAS@uspto.gov.(cid:160) For questions about the Office action itself, please contact the assigned
`trademark examining attorney.(cid:160) E-mail communications will not be accepted as responses to Office actions; therefore, do not respond to
`
`(cid:160)(cid:160)
`(cid:160)
`(cid:160)
`
`
`this Office action by e-mail.
`
`(cid:160) A
`
`ll informal e-mail communications relevant to this application will be placed in the official application record.
`
`(cid:160) W
`
`HO MUST SIGN THE RESPONSE:(cid:160) It must be personally signed by an individual applicant or someone with legal authority to bind an
`applicant (i.e., a corporate officer, a general partner, all joint applicants).(cid:160) If an applicant is represented by an attorney, the attorney must sign the
`
`response.(cid:160)(cid:160)
`
`PERIODICALLY CHECK THE STATUS OF THE APPLICATION: (cid:160) To ensure that applicant does not miss crucial deadlines or official
`notices, check the status of the application every three to four months using the Trademark Status and Document Retrieval (TSDR) system at
`http://tsdr.uspto.gov/. (cid:160) Please keep a copy of the TSDR status screen. (cid:160) If the status shows no change for more than six months, contact the
`Trademark Assistance Center by e-mail at TrademarkAssistanceCenter@uspto.gov or call 1-800-786-9199. (cid:160) For more information on checking
`status, see http://www.uspto.gov/trademarks/process/status/.
`
`(cid:160) T
`
`O UPDATE CORRESPONDENCE/E-MAIL ADDRESS:(cid:160) Use the TEAS form at http://www.uspto.gov/trademarks/teas/correspondence.jsp.
`
`(cid:160)(cid:160)
`
`
`SILVER ION RELEASE FROM A SILVER FIBER HYDROGEL WOUND DRESSING
`A. Fluder
`J. Laudanor, J. Smiel|3, S. Snyder’. F. Fnrman“ ‘AquaMed Technologies Inc. 3Al|iqua |nc., 3JMS Clinical LLC. ‘Advancai Clinical Perspectives LLC. 5Cenler for Wound Healing Inc.
`
`mm
`mum... nmnm.
`~...«,.n..
`
`ABSTRACT
`
`OBJECTIVE
`Tuaamnmanmummpunmasummimmzmmmaagg
`mumna-ypzmmannmymmuugmumsnitsmasmapumm
`
`5Emilia Cnn::lII7xIiulI If Age VMSIE film in Walnr
`'-I‘
`....
`
`-=3-.5
`
`kvnltmmwmfllwfl
`
`=e3!F9I:95
`
`-Tl|aivevinnnha|9Dlmi9wnsnvefllllleninnIDic1nIalhs(az4-new
`iuinfimwwudahyllinntwdwnzimmmnmafimupeuudslbwm.
`-Tunsnnaswasm«uuma.unusium.uumnmny,anavuncaim
`sunywasmumaausimgnass snu'umuunuimgamiunpunnau.ain|M5n
`iunlamuwanr.
`nfihuhycicgelsallnflnatalndlflulllts-dnghdn-hwimdwdnlurahnn
`123»1:u2g'I\N5)mla'II:Ibmed manmanunumarcruzanm-5
`_11|alncIiIer5Iuem|adl1nph:e,
`_nanmunzeu:n|:gmwmrannamm:imumpumnunoua
`wuinduunna
`.umrvomnamsmnaamumuyangunamgwaiguaaramm1:unu
`-Msumuun.sh:m1m9unychugaIs:aii-gweignaarxsu¢:f1n
`-WzIhrwNSwfllWhxdWdly24hnIls.11I9wluI|aaIeudH1'|EII;Bwas
`hudmmsmfiawlflxfiuwifll.
`.'nnaiquimauuwannnarnuinifiu2un:pari:dmdattarIndgInIn244n:
`Dirnuuwasrauiuen.
`.TIniuarhu¢x-uxauvndinidlrnnataiuuimnyisswasnmmuudlyatxuic
`
`Silvwlnnflydmgal nmssinq-:1
`
`mmunsmmsnhnyiuuuxanunyru-mnnm=_
`nxIta1:vna|i1I.i|mIl|dhadarJfIxPq+,MInr:l)'
`'
`Ihe
`II\eu|:el|fira4II3Il31.fllnrM|'d|_Ihas:n‘!as
`n1mcIs|i:1:irn1,1'I\eulnfln:wzlnphad'II
`!lflldu'lIi||‘lhflmAUIlal\Ic(HlDtIBI24I’I'IIL
`wilflfmmpulifudwalnrauryzl
`n..nayn,axn:c|sw.augu'luzxxiun1a-1imou1
`
`mmiuwumpum
`-uuaugu.-ma-un-uvia-h.u--a-LIV!
`
`INTRODUC ON SILVER CHEM STRY
`Ehcvuvfisnuusbddlldyuranfillqlhealltuizwlainldiluisdqndml
`mummmmswmimipggnispmpmmmbiumwmmm
`maaiiymm.a:u.imnu:n;a|mnmuuna|nnnum.aa'=
`w
`npruzarnnam
`pluhsyillheas
` “'“i"'°“"
`
`-mmmaumuxsmymmmmmuunmmmmmm
`D_ay_1al|1|hys maamisgmunmaasuimainmnmcmnyuning
`amlalvulintiqy,“
`-mmgnuei-izuduna:muusa.arnnuaa5m@mastuwummi1_
`I|9y|:lmIdsnI1‘hlui\nI\atmgInIx;aI;:x:1sd:nvn|1“
`-sawyimuaanimmmmmmmnesigvuhnmusmusammms
`ixmmammwunrasaimaat-ates:
`'-ummdmlmmlmmw
`Imtuannaynaaniiupunadmatmsaiauasanhwwmmwtmnsayba
`alIi:'|nIn‘Iinui|n1
`-0ve(imn.hIesioarfln':fllm1j1u1fln|inu"q]mihaflIar|in|sI|psIfi§d
`um)nuyumammmaua|m_ami»gm:mssIua-mtimmiaamm
`maununmapmimieumanayna
`-siumamanmmmuxsmlnmnsnmuiumymnpamn-msnnns
`nu’ tilhlallldllhun sown.’ :n|iecIuuIp:IisaI|sniII1aIIIar§udius:'a
`mmmumu
`
`-Tnesiuarinarhyd-uyuuunuauuiucanaauniuuuunuinnLu.:nmu
`nmmmamnmsmruummuuimumricmuuimiviyvucwvosawsn
`mtumermnssnminummm
`-Hfllyu-Kumflhisdiumhiuaudmexfinimnmflmiuum
`llI‘.Il!IIBI!i|fl&'DlIizmW$§(EulluflEDmN5ml|fliEIlI,
`-firmuiummmmmmsmaasmwmarmyumaucmwmm.
`lldomus
`............_.....,......=.....
`., ...._......_..
`_:Ir
`1 :.:?_n‘u.n.-.._e.p...,...__..1hu_....n._a._m_.nn_..,
`1 ug..:.‘q_u_._¢.:n_.: »..«....a;.‘u......._....:_".‘¢..........u.....«..,,.....
`zmluugupsnan
`. u....:_.g;‘:...v..—..-_.._-.._.,._..m.._npu...n._....,.._..
`1 u.am..c..n.uv_H..-a...»-rn..aa......
`..._,...n._.......
`unnulflqainznnllt usnn.-|qmJn>nn1nIz1qfimn.1n
`1 mule.»-uJ.§_£u,.‘;“.‘u’.5&-.g.mga......n.._u.;q.a.._:.na.u
`7, mu: pqmmnun
`.--nu-.-.--...n..n-.—.p..m...
`.-nun»-un._.....n—un:u.amm«uusu.au¢n.
`1 mqqn.n...ua-.....-;a....m...u.._..._...........n.....:
`.....,...._.n..._u.._....._.o.un.-....a,...._..u._.=.n......_
`...............,.,.a.-..x:...qc.....w .,...u.,m.1
`n. _n...uu.m..-..n._m-nan-gnu n.m..u-nu-uamn
`un_l..n....;.;‘p::i..-u-..p....-q......-an-....xn.—.-.-
`
`nu2o1:spingsymp.uaumouAd—udwu.dcmmuq,Muy1-5,201:. n...v-,cuIumdu
`
`
`
`BOSTON -
`,
`
`'
`
`_
`
`' S0 dS in Chronic Wound
`
`_
`
`A
`
`T
`
`‘
`
`
`
`
`
` SI. Mary s Doesma Distance
`to FFMHI Patients
`
`Make Cl world‘ ‘
`of difference.
`
`No1'tlmrestern
`’ wan mm
`
`OpUmum—lJ\/
`Enligflm
`$<-uh.» I‘
`, ,m my
`\
`\ mmm .
`
`
`A
`
`osonics
`L/....._.._
`
`CABS Wound Care Best Practices are Elusive
`
`
`rz-am-u . .......
` y...........ym....y..........mu.,.....yy,...y.
`
`
`mu.
`4mm-ul-A5.Haul!....._ .y.y......W_.....IuIm1:u1.lnA:wuIDvHnvnI>
`nn'(V; _...::v::;ux'...y.A,:m.v..u.»~...ry my y....,.-q:.M,y.~ym
`mm:4101!! rnszmnsrlnillzrvn mum....m.....mM.n:mHwmnaniumIm
`mm. IIl"1'l‘(l1WIIfIIVYVF1!WIVV“]Xr, mm...y...y..«g
`3fJ1..n..‘§,".,"¢.m£.T‘..m.m"y.m “"' """
`L m.n.a;»‘.y.7I...y.y_'_.;..—..;...:y..=yElma-EmhnzikImc\.ntm>vnx.\mum:umann:
`Hummu M...my..y“mmn:.n..".mmmMno:u:Imn.mvunmy
`ma:y.up
`g..g=.-Kim..K..»..a-wwuyy...weuuv>\k<-4hIIIrV;l~Vn|r)lr-<l‘1k<Ii-ANWcméy
`mamnurmeml
`ls:mwtz:nsnrn~nn:u,nyr,vyvuwIImxuIt:mn:mnLYu~y.m:yun
`wadmm.gm.’W...1“I¢I9u«leA:~re-ndguieiweéy-m..-u..;.¢..y
`.
`M0,... mun.
`
` -maymy...mm.,m.,..y..eM,.,ay:»....y.y.n......y.....«.».
`yum. ....ymwI:-mm-rI;<wh-numm... mumm"m.Imus‘y.
` am.u.yy....,,..mgnncm itsW..m>..y.m-ymurv mnpm.“y. ..
`wags:..y. 34..y.Mm»:\....y..... ha-vi.....(......y...‘ ..-.,= ..y..y..y.,....
`..mm..y....... m,...m.yz.=....n um...‘ mm...
`..m.m...ym,
`..«.-mu....
`y ..m.,,
`Im.gm
`-y.n..3......11 ....._.y...y..,. y.
`xNn«\.....». .y....y.......~ mm~ArI\Ifl.-
`. m..y.m Mum.» tnnnmlzrvulxvlalmnaunuvnnwlvl-Imuuxul
`val‘H145F5}K‘>u\|ulYI.53lu1lA<\H\z‘;Iun|lul ...,..m..m,. ».....y,._.w..
`my
`u.m1v,\muz-.m: mun ........y.....y.
`man:
`rr-wnn<I::v=Itnm7n>up
`5 W.W1:91.\y.,y.y..y y_y._y. ll sun-I»_..,uus--,..y...y,.. 5(mwnmh
`:!\5suvuw>wlxVvm\I:1>vmwmmu
`.y..m.=..»m....a....mmmm. ‘Vhc
`immrmnlwutumm-l‘vum.I.:. .-mmgm ».m...... wnIuAnrnrm:un'4u
`L :/Ln.10 numm¢.mn=m§_.5:mymy :4:.m.m.m2.mmash un
`|l)“JxV\9\£1nI)Iu|lvr:-\maurllh:4Iy11w‘.—lImlIk514z-I
`ymm..yy...m.n.,w.....<,......m.,...m..~.»,m.;.y.m.n.,.¢. W... .....
`‘Aw..y. 4..y.y.u..MyN.-.
`.yM...)M.“
`.....
`..
`mmmm...” u.munumarenarm»y..-W:..—.y..y ,...m..y...y...mix:
` v
`Elma.... ’I‘r‘nrv:uw.=.......m,nu.;umW...“Mm..ym...m..
`1......m.y....an......y.mw1rrl:nIInInwrnr:Ixnktzzy1l'wnI-ulna:-nuvxl
`"“"”"’' "";’."::.‘1fiy""".‘L'yfi"“"T"T“"‘f‘.i"1‘fi”fif§fiJ.""‘
`
`»»..m.m an....mmm............=.m.,y....m.:..n_=.-..Iulnn
`m.ay..y ,.._.....w.y.yannsy ..g_.,...mun....y.... aw‘,am
`yum...mmmm:mm y.WINEmmnalnumvmzmlmnllvnrnImuwunl
`..n,.,y.y_.w.m My .«~l(DIIlIIUr>«I~4lhrrVJG4s\VEIVlrv1aIIWPIlVIVr1KIvr
` r:‘nwn::mv|an:mt{.-ypL:L<nl;'lw~nnn:4..awzur.;.u..Vy‘..:-T. mnu:
`s..m...........,y..s»-
`'
`'5i~ y. .~...,..(.._...y...,..y.y......m...,y........_......,‘m..
`
`mmi i _
`.m....m y... .y...m.Wmm,..y..,y....m. mm
`5.......m...umm..nssnmtcvcaaomaymnuxammmmmm...».....
`._.n.M. lI«V‘!'V\nn-1n.«>—;r-wrrvvrylflmIrr-vwnm¢\rvV'lv1hnImVVh-rm
`A‘.:'-u.,,._:.‘.uy_‘..V..p-y mu F‘levv«|:‘::-w..1_.u.fm:«m..m.. wk-mL:‘p4-‘:4 55.5..
`I»! y-m.,...m.M.9.rruuwrwlvwmax...
`uTyT=‘E§.‘n‘;'.m'"‘.'-m.y»p.y-‘m$.'m'S‘s‘Sa‘y-‘:"u§7-.ma-é'm.§aas‘3.q'u.7v2u...u.
`um ‘um..;nomi:ml-ml!rlnmrlrv
`wmwamru nnlnrnacunuruml
`M... ...y.... .....mM... WV/l"lIvr-r|:unHIlll!PI1'7"l'MWrt'»«a.nn .,..
`my.unu-4—uu\1W....y.—....u.-s.m....,y..Mn.(‘mmmu..:.m....
`n.u....«»...........Minn-um 1..may
`a...Mrlin-slruvw ......u.s m...
`y.~.......y..,y..nmrl-I,nm
`mm.
`.m...u-~....y.....-......m
`
`y. H,~.._.,..y..my.“mmW _.mnhIAXmloym.y.y.,_y.,m.‘.y.
`'.I7;uul¢I~uv r-rman‘
`3...1.:5..m.m......y.y_:=.uuyflynm.y.It;-|unnI_n:ndn1!vvnr::i:vw1lwnwna
`-mm... y..m..m : ...y.y.y...y.m~; .m....mc umm
`.m.m. may-rwwur mm mm] ».m..M..m IvI\,IVVln~17lr
`'fl'VYEr‘\Iu\'1
`W.‘-u...k...,
`KANfl}l¥r4IHIAA|Ai"K
`-.yw.y.y.......-
`w.iy.:...yyZ...,Z..my.., mi”-,...,‘-"A.«v,f‘1"%‘»S...“y"..«y...”;i".‘smyL"y'mu’.
`2 M... .....m..m...m
` .sawmmmu =m..m.m...;...mmmulhvnxmm..._y y... zm:
`§I....yy..ymw1...fi'.'m...y.’;y"¢"M;Tc'...'...my.La Sm
`— Eng mm ,..,..
`.4 y
`smumnanncxes
`. [>aI-Cllirnn aw. Zmnlew ...,..Wm.,...a..y.nc.mm..,..»,.yy. hgnhflfi
`, Vmlfldwlrrw W ‘VEVItClIVCV<‘r1IVxIlIll<E"‘ Mkukn EVU-ww|1nHhn|eE4mvuum:rI|
`
`x AYFSTmum rs
`
`
`Arrya.:....=....4.......mnlnmlnmrd
`...m..mnomam.hangus.....
`flIlNlG.‘Vl1IVllVV‘4'IUIIVV!IlVIIi
`....
`,...,...aflngu|IIrri3IlHnqand
`......u..y....z
`0 m
`0 Nu
`(Unma-
`
`
`
` sTw“.'.y..”:HVIVIIKAIVYLTV 41'...
`
`
`u....y~,m. naumm .y..
`.-
`
`
`
`FREE [I
`v mg.»..m.
`
`2 mmc..m.m.....uu..nmnbcr
`.4-asmm... M... .-1
`2 n..mm. mun-mm.
`2 :.y...m_.y..Hvuuudfln-ME‘
`« y.......y-..._..m
`Ema y
`
`E
`
`.m.mn...m.,».;.m my
`. mnur1AouHv=J-zn RE
`on :02RESOURCES
`. y.m.».... ....,.. rsIv1r1»VF4’.?Av:Fnrr:mnAlIH !Vruvn:rumI’n.nw.mrsIlr\|V]losx>
`
`VmeclwvlCumrul Ibfluy
`{ sum
`
`oCnmrlvns
`Mvvrrcml
`¢
`
`B61}:nm 1.ccmmrm
`
`Lrtim ~
`mM Bun
`
`Resrzlnlwy Emurth:
`y/LyslsMeshm\H£Y5
`-.y.n.,......r.,......,...mn...-
`y»w..,......~...,,,;“.;.....y»y
`can-s Surwu R-swnsnInem.
`Dulnmaxm W:s\Amca
`y......»..y..m.yu.a.y..m.......
`lunirvvr-Ivvvmn:n:Innmr*7nrm
`I
`\ —u..mya.w
`
`FuAu:HnIa Fuhlu: Heivmu an
`Annslvfil:Pammrummw.
`.
`.
`N
`.r _:.m.m~..y....
`- ..y....y.«.yn...,,m...««...M.
`law.--ad..M;was m-I
`mayAnu5lP1Ic ems sum. my M
`Blaodsweam nmmyms mumcafly.
`mmnma
`H .
`,
`,,,y.-mu...:
`M:lr1nWyK{N\nwn' my. N.1y:l!
`
`
` FEATURED LINKS
`w§1mn—Lum Dniwvev sum
`..fni3.'“~?n'.‘..‘3.‘T'g"t‘¢:‘C.'(:”§i'L';‘.'§I1.‘!.’l7::3:‘:fl5.
`y.m'".'2.".'.y1Z‘.“.531"~3’r‘.":?*‘“
`_...Wy..-u.-,w......,..y,....<... u.......,
`15mrm “mu.
`
`
`
`
`
`
`To:
`
`Subject:
`
`Sent:
`
`Sent As:
`
`Attachments:
`
`KCI LICENSING, INC. (ipdocket@dykema.com)
`
`U.S. TRADEMARK APPLICATION NO. 86856090 - ION PROGRESS - 709800.3676
`
`4/19/2016 11:01:18 AM
`
`ECOM108@USPTO.GOV
`
`UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
`
`IMPORTANT NOTICE REGARDING YOUR
`U.S. TRADEMARK APPLICATION
`
`USPTO OFFICE ACTION (OFFICIAL LETTER) HAS ISSUED
`ON 4/19/2016 FOR U.S. APPLICATION SERIAL NO. 86856090
`
`Please follow the instructions below:
`
`(cid:160) (
`
`1)(cid:160) TO READ THE LETTER:(cid:160) Click on this link or go to http://tsdr.uspto.gov, enter the U.S. application serial number, and click on
`“Documents.”
`
`(cid:160) T
`
`he Office action may not be immediately viewable, to allow for necessary system updates of the application, but will be available within 24
`hours of this e-mail notification.
`
`(cid:160) (
`
`2)(cid:160) TIMELY RESPONSE IS REQUIRED:(cid:160) Please carefully review the Office action to determine (1) how to respond, and (2) the applicable
`response time period.(cid:160) Your response deadline will be calculated from 4/19/2016 (or sooner if specified in the Office action).(cid:160) For information
`regarding response time periods, see http://www.uspto.gov/trademarks/process/status/responsetime.jsp.
`
`(cid:160) D
`
`o NOT hit “Reply” to this e-mail notification, or otherwise e-mail your response because the USPTO does NOT accept e-mails as
`responses to Office actions.(cid:160)
`Instead, the USPTO recommends that you respond online using the Trademark Electronic Application System
`(TEAS) response form located at http://www.uspto.gov/trademarks/teas/response_forms.jsp.
`
`(cid:160) (
`
`3)(cid:160) QUESTIONS:(cid:160) For questions about the contents of the Office action itself, please contact the assigned trademark examining attorney.(cid:160) For
`technical assistance in accessing or viewing the Office action in the Trademark Status and Document Retrieval (TSDR) system, please e-mail
`TSDR@uspto.gov.
`
`WARNING
`
`(cid:160) F
`
`ailure to file the required response by the applicable response deadline will result in the ABANDONMENT of your application.(cid:160) For
`more information regarding abandonment, see http://www.uspto.gov/trademarks/basics/abandon.jsp.
`
`PRIVATE COMPANY SOLICITATIONS REGARDING YOUR APPLICATION:(cid:160) Private companies not associated with the USPTO are
`using information provided in trademark applications to mail or e-mail trademark-related solicitations.(cid:160) These companies often use names that
`closely resemble the USPTO and their solicitations may look like an official government document.(cid:160) Many solicitations require that you pay
`
`(cid:160)(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`(cid:160)
`
`
`“fees.” (cid:160)(cid:160)
`
`Please carefully review all correspondence you receive regarding this application to make sure that you are responding to an official document
`from the USPTO rather than a private company solicitation.(cid:160) All official USPTO correspondence will be mailed only from the “United States
`Patent and Trademark Office” in Alexandria, VA; or sent by e-mail from the domain “@uspto.gov.” (cid:160) For more information on how to handle
`private company solicitations, see http://www.uspto.gov/trademarks/solicitation_warnings.jsp.
`
`(cid:160)(cid:160)
`